Malaysia’s MIMOS, the national applied research and development agency, has made an important breakthrough in medical device technology. It has launched the first ever clinically tested, non-invasive, non-intrusive and non-destructive device, called GlucoSenz, for blood glucose monitoring. The device applies chemometrics ...